Paul A. Dayton

Paul A. Dayton, PhD, is a UNC Lineberger Comprehensive Cancer Center member, Professor and Academic Director at the UNC Eshelman School of Pharmacy and Associate Professor in the Department of Biomedical Engineering at UNC-Chapel Hill. Dayton Lab focuses on contrast-enhanced ultrasound pre-clinical research.

Associate Professor
UNC-Chapel Hill
Clinical Research
Breast Cancer

Area of interest

Research in contrast enhanced ultrasound imaging techniques for the assessment of cancer and other diseases. Non-invasive imaging of angiogenesis, cancer biomarkers, and blood perfusion. Applications of ultrasound in enhanced drug delivery and targeted therapeutics.

Awards and Honors

Top Story (senior author), UNC Lineberger Cancer Center, “Preclinical studies use specialized ultrasound to detect presence of cancer”, July 10, 2012

Poster Merit award (senior author), “New Nanodroplets Increase Tissue Ablation in Response to High Intensity Focused Ultrasound”, Leeds Microbubble Symposium.

Best poster award (senior author), “Design and Testing of Acoustically-Active Therapeutic Nanocapsule Delivery Vehicles for Ultrasound-Targeted Chemotherapy”, UNC Lineberger Cancer Center Symposium, May 2011.

Find publications on PubMed

Reach NC profile

Caption available.